Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02838420
What this trial is testing

Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer
Hoffmann-La Roche 187
Post-approval studies (Phase 4)Ended earlyNCT00855413
What this trial is testing

HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine

Who this might be right for
Acute HIV InfectionHIV Infections
University of North Carolina, Chapel Hill 15
Not applicableStudy completedNCT01942213
What this trial is testing

Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.

Who this might be right for
Neovascular Age Related Macular Degeneration
Prism Vision Group 136
Not applicableStudy completedNCT00050908
What this trial is testing

Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Testing effectiveness (Phase 2)Study completedNCT04967417
What this trial is testing

Pembrolizumab With Standard Cytotoxic Chemotherapy in Treatment Naive NSCLC Patients With Asymptomatic Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
Samsung Medical Center 13
Large-scale testing (Phase 3)Study completedNCT01212991
What this trial is testing

A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer 1,717
Testing effectiveness (Phase 2)Study completedNCT06560489
What this trial is testing

Pharmacokinetics and Efficacy of Multiple Dosing of LP-98 for Injection in HIV-infected Patients

Who this might be right for
Hiv
Shanxi Kangbao Biological Product Co., Ltd. 40
Large-scale testing (Phase 3)Looking for participantsNCT07068074
What this trial is testing

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Who this might be right for
Cutaneous Melanoma
ECOG-ACRIN Cancer Research Group 428
Testing effectiveness (Phase 2)Looking for participantsNCT07350850
What this trial is testing

A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL

Who this might be right for
PCNSLPrimary Central Nervous System Lymphoma
Tongji Hospital 77
Large-scale testing (Phase 3)Study completedNCT02757352
What this trial is testing

Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis

Who this might be right for
Axial Spondyloarthritis
Eli Lilly and Company 303
Testing effectiveness (Phase 2)Study completedNCT00528060
What this trial is testing

Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 35
Large-scale testing (Phase 3)Study completedNCT00300287
What this trial is testing

A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 150
Large-scale testing (Phase 3)Study completedNCT02136069
What this trial is testing

A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Ulcerative Colitis
Hoffmann-La Roche 397
Not applicableStudy completedNCT00100594
What this trial is testing

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Early research (Phase 1)Ended earlyNCT01989052
What this trial is testing

Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma

Who this might be right for
Malignant Glioma (WHO Grade III or IV)
Annick Desjardins 9
Testing effectiveness (Phase 2)Study completedNCT00005865
What this trial is testing

Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00036452
What this trial is testing

Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 402
Not applicableStudy completedNCT00004855
What this trial is testing

Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Testing effectiveness (Phase 2)Looking for participantsNCT07234058
What this trial is testing

Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma

Who this might be right for
Pleural Mesotheliomas
Intergroupe Francophone de Cancerologie Thoracique 126
Not applicableNot Yet RecruitingNCT07250815
What this trial is testing

A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 23,900
Next Page